Compare MKSI & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MKSI | BAX |
|---|---|---|
| Founded | 1961 | 1931 |
| Country | United States | United States |
| Employees | N/A | 38000 |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 10.0B |
| IPO Year | 1999 | N/A |
| Metric | MKSI | BAX |
|---|---|---|
| Price | $164.05 | $19.37 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 10 |
| Target Price | ★ $154.60 | $25.67 |
| AVG Volume (30 Days) | 857.4K | ★ 8.0M |
| Earning Date | 02-11-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.54% | 0.21% |
| EPS Growth | ★ 820.97 | N/A |
| EPS | ★ 4.12 | N/A |
| Revenue | $3,832,000,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $10.71 | $5.20 |
| Revenue Next Year | $7.46 | $2.00 |
| P/E Ratio | $39.88 | ★ N/A |
| Revenue Growth | ★ 8.13 | 3.90 |
| 52 Week Low | $54.84 | $17.40 |
| 52 Week High | $170.37 | $37.74 |
| Indicator | MKSI | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 58.49 | 54.00 |
| Support Level | $160.00 | $18.65 |
| Resistance Level | $160.78 | $19.43 |
| Average True Range (ATR) | 5.32 | 0.45 |
| MACD | -0.29 | 0.11 |
| Stochastic Oscillator | 73.67 | 73.16 |
MKS Inc formerly, MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others, used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.